UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 4.610

Sortiert nach

Timing of Coronary Invasive Strategy in Non-ST-Segment Elevation Acute Coronary Syndromes and Clinical Outcomes: An Updated Meta-Analysis

JACC. Cardiovascular interventions, 2016-11, Vol.9 (22), p.2267-2276

2016

Volltextzugriff (PDF)

Sex differences in time trends in acute coronary syndrome management and in 12-month lethality: Data from the French MONICA registries

International journal of cardiology, 2022-08, Vol.361, p.103-108

2022

Volltextzugriff (PDF)

A Risk Score to Predict Bleeding in Patients With Acute Coronary Syndromes

Journal of the American College of Cardiology, 2010-06, Vol.55 (23), p.2556-2566

2010

Volltextzugriff (PDF)

Early and Late Benefits of Prasugrel in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention : A TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) Analysis

Journal of the American College of Cardiology, 2008-05, Vol.51 (21), p.2028-2033

2008

Volltextzugriff (PDF)

Efficacy of high-dose atorvastatin or rosuvastatin loading in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials with GRADE qualification of available evidence

European journal of clinical pharmacology, 2022, Vol.78 (1), p.111-126

2022

Volltextzugriff (PDF)

Optimizing P2Y12 Receptor Inhibition in Patients With Acute Coronary Syndrome on the Basis of Platelet Function Testing: Impact of Prasugrel and High-Dose Clopidogrel

Journal of the American College of Cardiology, 2014-03, Vol.63 (11), p.1061-1070

2014

Volltextzugriff (PDF)

Clinical Impact of CYP2C19 Genotype on Clopidogrel-Based Antiplatelet Therapy After Percutaneous Coronary Intervention

JACC. Cardiovascular interventions, 2023-04, Vol.16 (7), p.829-843

2023

Volltextzugriff (PDF)

Randomized evaluation of 5-month Ticagrelor monotherapy after 1-month dual-antiplatelet therapy in patients with acute coronary syndrome treated with drug-coated balloons: REC-CAGEFREE II trial rationale and design

BMC cardiovascular disorders, 2024-01, Vol.24 (1), p.62-62, Article 62

2024

Volltextzugriff (PDF)

Angiographic and clinical outcomes among patients with acute coronary syndromes presenting with isolated anterior ST-segment depression: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) substudy

JACC. Cardiovascular interventions, 2010-08, Vol.3 (8), p.806-811

2010

Volltextzugriff (PDF)

The Effects of the COVID-19 Pandemic on the Clinical Practices of Cardiologists

Current problems in cardiology, 2024-01, Vol.49 (1), p.102092-102092, Article 102092

Gitmez, Mesut

2024

Volltextzugriff (PDF)

Acute coronary syndrome in patients treated by vitamin K antagonists or non-vitamin K antagonist oral anticoagulants: Proposed management algorithm for the first 48hours

Archives of cardiovascular diseases, 2024-05, Vol.117 (5), p.351-357

2024

Volltextzugriff (PDF)

Efficacy and Safety of Ticagrelor versus Clopidogrel with Different Dosage in High-risk Patients with Acute Coronary Syndrome

International journal of cardiology, 2017-02, Vol.228, p.275-279

2017

Volltextzugriff (PDF)

Reply: Short Duration of DAPT vs De-Escalation After Percutaneous Coronary Intervention for Acute Coronary Syndromes

JACC. Cardiovascular interventions, 2022-05, Vol.15 (9), p.999-1000

2022

Volltextzugriff (PDF)

Short Duration of DAPT vs De-Escalation After Percutaneous Coronary Intervention for Acute Coronary Syndromes

JACC. Cardiovascular interventions, 2022-05, Vol.15 (9), p.999-999

2022

Volltextzugriff (PDF)

2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Journal of the American College of Cardiology, 2014-12, Vol.64 (24), p.e139-e228

2014

Volltextzugriff (PDF)

Real-world evidence of switching P2Y12 receptor-inhibiting therapies to prasugrel after PCI in patients with ACS: results from EFF-K registry

BMC cardiovascular disorders, 2023-01, Vol.23 (1), p.6-6, Article 6

2023

Volltextzugriff (PDF)

Impact of Close Surveillance on Dual-Antiplatelet Therapy Compliance in Myocardial Infarction Patients Post-Percutaneous Coronary Intervention

Cardiovascular revascularization medicine, 2023-03, Vol.48, p.7-14

2023

Volltextzugriff (PDF)

Timing, Selection, Modulation, and Duration of P2Y 12 Inhibitors for Patients With Acute Coronary Syndromes Undergoing PCI

JACC. Cardiovascular interventions, 2023-01, Vol.16 (1), p.1

2023

Volltextzugriff (PDF)

Safety and Efficacy of Bivalirudin With and Without Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention : 1-Year Results From the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Trial

Journal of the American College of Cardiology, 2008-09, Vol.52 (10), p.807-814

2008

Volltextzugriff (PDF)

Assessment of Vascular Dysfunction in Patients Without Obstructive Coronary Artery Disease: Why, How, and When

JACC. Cardiovascular interventions, 2020-08, Vol.13 (16), p.1847-1864

2020

Volltextzugriff (PDF)

Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS)

Journal of the American College of Cardiology, 2019-11, Vol.74 (20), p.2452-2462

2019

Volltextzugriff (PDF)

Concomitant administration of clopidogrel with statins or calcium-channel blockers: insights from the TRITON-TIMI 38 (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38)

JACC. Cardiovascular interventions, 2013-12, Vol.6 (12), p.1275-1281

2013

Volltextzugriff (PDF)

Safety and Efficacy of Switching From Either Unfractionated Heparin or Enoxaparin to Bivalirudin in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Managed With an Invasive Strategy : Results From the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Trial

Journal of the American College of Cardiology, 2008-05, Vol.51 (18), p.1734-1741

2008

Volltextzugriff (PDF)

Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents

Cardiovascular diabetology, 2021-07, Vol.20 (1), p.137-137, Article 137

2021

Volltextzugriff (PDF)

In-Stent Restenosis in the Drug-Eluting Stent Era

Journal of the American College of Cardiology, 2010-11, Vol.56 (23), p.1897-1907

2010

Volltextzugriff (PDF)

1 – 25 von 4.610

Suche als RSS-Feed

Aktive Filter

KollektionJournals@Ovid Complete

KollektionIngentaConnect

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(4.446)
Mit Volltextzugriff
(4.298)

Publikationsform

Sprache

7 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(3.877)
Humans
(3.831)
Life Sciences & Biomedicine
(3.659)
Cardiovascular System & Cardiology
(2.399)
Cardiac & Cardiovascular Systems
(2.238)
Male
(2.230)
Acute Coronary Syndromes
(2.189)
Female
(2.159)
Middle Aged
(1.807)
Aged
(1.678)
Acute Coronary Syndrome
(1.477)
Treatment Outcome
(1.291)
Heart Attacks
(1.263)
Cardiology
(1.153)
Acute Coronary Syndrome - Therapy
(1.148)
Risk Factors
(1.115)
Cardiovascular
(1.109)
Cardiovascular Disease
(1.026)
Acute Coronary Syndrome - Drug Therapy
(861)
Mortality
(853)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Timing of Coronary Invasive Strategy in Non-ST-Segment Elevation Acute Coronary Syndromes and Clinical Outcomes: An Updated Meta-Analysis

Sex differences in time trends in acute coronary syndrome management and in 12-month lethality: Data from the French MONICA registries

A Risk Score to Predict Bleeding in Patients With Acute Coronary Syndromes

Early and Late Benefits of Prasugrel in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention : A TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) Analysis

Efficacy of high-dose atorvastatin or rosuvastatin loading in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a meta-analysis of randomized controlled trials with GRADE qualification of available evidence

Optimizing P2Y12 Receptor Inhibition in Patients With Acute Coronary Syndrome on the Basis of Platelet Function Testing: Impact of Prasugrel and High-Dose Clopidogrel

Clinical Impact of CYP2C19 Genotype on Clopidogrel-Based Antiplatelet Therapy After Percutaneous Coronary Intervention

Randomized evaluation of 5-month Ticagrelor monotherapy after 1-month dual-antiplatelet therapy in patients with acute coronary syndrome treated with drug-coated balloons: REC-CAGEFREE II trial rationale and design

The Effects of the COVID-19 Pandemic on the Clinical Practices of Cardiologists

Acute coronary syndrome in patients treated by vitamin K antagonists or non-vitamin K antagonist oral anticoagulants: Proposed management algorithm for the first 48hours

Efficacy and Safety of Ticagrelor versus Clopidogrel with Different Dosage in High-risk Patients with Acute Coronary Syndrome

Reply: Short Duration of DAPT vs De-Escalation After Percutaneous Coronary Intervention for Acute Coronary Syndromes

Short Duration of DAPT vs De-Escalation After Percutaneous Coronary Intervention for Acute Coronary Syndromes

2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Real-world evidence of switching P2Y12 receptor-inhibiting therapies to prasugrel after PCI in patients with ACS: results from EFF-K registry

Impact of Close Surveillance on Dual-Antiplatelet Therapy Compliance in Myocardial Infarction Patients Post-Percutaneous Coronary Intervention

Timing, Selection, Modulation, and Duration of P2Y 12 Inhibitors for Patients With Acute Coronary Syndromes Undergoing PCI

Safety and Efficacy of Bivalirudin With and Without Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention : 1-Year Results From the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Trial

Assessment of Vascular Dysfunction in Patients Without Obstructive Coronary Artery Disease: Why, How, and When

Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS)

Concomitant administration of clopidogrel with statins or calcium-channel blockers: insights from the TRITON-TIMI 38 (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38)

Safety and Efficacy of Switching From Either Unfractionated Heparin or Enoxaparin to Bivalirudin in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Managed With an Invasive Strategy : Results From the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) Trial

Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents

In-Stent Restenosis in the Drug-Eluting Stent Era

Aktive Filter

Suchergebnisse filtern